The World Health Organization has issued a warning about growing resistance to the HIV antiretroviral drug dolutegravir. Surveys conducted in Malawi, Uganda, and Ukraine have shown that resistance levels among those receiving this medication are higher than expected. This resistance is particularly concerning as it is surpassing levels seen in clinical trials. The findings suggest that there is a need for increased monitoring and potential changes in treatment protocols to address this issue.
Source link
HIV: WHO reports “worrying” increase in resistance to key antiretroviral treatment
